Unraveling Deep Gray Matter Atrophy and Iron and Myelin Changes in Multiple Sclerosis

References

1. 1.↵
   1. Eshaghi A,
   2. Prados F,
   3. Brownlee WJ, et al

   . MAGNIMS study group. Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol 2018;83:210–22 doi:10.1002/ana.25145 pmid:29331092

   CrossRefPubMed
2. 2.↵
   1. Pontillo G,
   2. Cocozza S,
   3. Lanzillo R, et al

   . Determinants of deep gray matter atrophy in multiple sclerosis: a multimodal MRI study. AJNR Am J Neuroradiol 2019;40:99–106 doi:10.3174/ajnr.A5915 pmid:30573464

   Abstract/FREE Full Text
3. 3.↵
   1. Langkammer C,
   2. Liu T,
   3. Khalil M, et al

   . Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013;267:551–59 doi:10.1148/radiol.12120707 pmid:23315661

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Zivadinov R,
   2. Tavazzi E,
   3. Bergsland N, et al

   . Brain iron at quantitative MRI is associated with disability in multiple sclerosis. Radiology 2018;289:487–96 doi:10.1148/radiol.2018180136 pmid:30015589

   CrossRefPubMed
5. 5.↵
   1. Fujiwara E,
   2. Kmech JA,
   3. Cobzas D, et al

   . Cognitive implications of deep gray matter iron in multiple sclerosis. AJNR Am J Neuroradiol 2017;38:942–48 doi:10.3174/ajnr.A5109 pmid:28232497

   Abstract/FREE Full Text
6. 6.↵
   1. Stephenson E,
   2. Nathoo N,
   3. Mahjoub Y, et al

   . Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat Rev Neurol 2014;10:459–68 doi:10.1038/nrneurol.2014.118 pmid:25002107

   CrossRefPubMed
7. 7.↵
   1. O’Muircheartaigh J,
   2. Vavasour I,
   3. Ljungberg E, et al

   . Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis. Hum Brain Mapp 2019;40:2104–16 doi:10.1002/hbm.24510 pmid:30648315

   CrossRefPubMed
8. 8.↵
   1. Lutti A,
   2. Dick F,
   3. Sereno MI, et al

   . Using high-resolution quantitative mapping of R1 as an index of cortical myelination. Neuroimage 2014;93(Pt 2):176–88 doi:10.1016/j.neuroimage.2013.06.005 pmid:23756203

   CrossRefPubMed
9. 9.↵
   1. Stuber C,
   2. Morawski M,
   3. Schafer A, et al

   . Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. Neuroimage 2014;93(Pt 1):95–106 doi:10.1016/j.neuroimage.2014.02.026 pmid:24607447

   CrossRefPubMed
10. 10.↵
    1. Moller HE,
    2. Bossoni L,
    3. Connor JR, et al

    . Iron, myelin, and the brain: neuroimaging meets neurobiology. Trends Neurosci 2019;42:384–401 doi:10.1016/j.tins.2019.03.009 pmid:31047721

    CrossRefPubMed
11. 11.↵
    1. Schweser F,
    2. Raffaini Duarte Martins AL,
    3. Hagemeier J, et al

    . Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: a proposed mechanistic relationship between inflammation and oligodendrocyte vitality. Neuroimage 2018;167:438–52 doi:10.1016/j.neuroimage.2017.10.063 pmid:29097315

    CrossRefPubMed
12. 12.↵
    1. Hernandez-Torres E,
    2. Wiggermann V,
    3. Machan L, et al

    . Increased mean R2* in the deep gray matter of multiple sclerosis patients: have we been measuring atrophy? J Magn Reson Imaging 2019;50:201–08 doi:10.1002/jmri.26561 pmid:30511803

    CrossRefPubMed
13. 13.↵
    1. Polman CH,
    2. Reingold SC,
    3. Banwell B, et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Kurtzke JF

    . Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444–52 doi:10.1212/wnl.33.11.1444 pmid:6685237

    Abstract/FREE Full Text
15. 15.↵
    1. Lublin FD

    . New multiple sclerosis phenotypic classification. Eur Neurol 2014;72 Suppl 1:1–5 doi:10.1159/000367614 pmid:25278115

    CrossRefPubMed
16. 16.↵
    1. Palma G,
    2. Tedeschi E,
    3. Borrelli P, et al

    . A novel multiparametric approach to 3D quantitative MRI of the brain. PLoS One 2015;10:e0134963 doi:10.1371/journal.pone.0134963 pmid:26284778

    CrossRefPubMed
17. 17.↵
    1. Monti S,
    2. Borrelli P,
    3. Tedeschi E, et al

    . RESUME: turning an SWI acquisition into a fast qMRI protocol. PLoS One 2017;12:e0189933 doi:10.1371/journal.pone.0189933 pmid:29261786

    CrossRefPubMed
18. 18.↵
    1. Rooney WD,
    2. Johnson G,
    3. Li X, et al

    . Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med 2007;57:308–18 doi:10.1002/mrm.21122 pmid:17260370

    CrossRefPubMed
19. 19.↵
    1. Patenaude B,
    2. Smith SM,
    3. Kennedy DN, et al

    . A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907–22 doi:10.1016/j.neuroimage.2011.02.046 pmid:21352927

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Hanspach J,
    2. Dwyer MG,
    3. Bergsland NP, et al

    . Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): toward improved atlas- and voxel-based analyses (VBA). J Magn Reson Imaging 2017;46:1474–84 doi:10.1002/jmri.25671 pmid:28263417

    CrossRefPubMed
21. 21.↵
    1. Avants BB,
    2. Tustison NJ,
    3. Song G, et al

    . A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 2011;54:2033–44 doi:10.1016/j.neuroimage.2010.09.025 pmid:20851191

    CrossRefPubMed
22. 22.↵
    1. Zhang Y,
    2. Wei H,
    3. Cronin MJ, et al

    . Longitudinal atlas for normative human brain development and aging over the lifespan using quantitative susceptibility mapping. Neuroimage 2018;171:176–89 doi:10.1016/j.neuroimage.2018.01.008 pmid:29325780

    CrossRefPubMed
23. 23.↵
    1. Smith SM,
    2. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98 doi:10.1016/j.neuroimage.2008.03.061 pmid:18501637

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Stuber C,
    2. Pitt D,
    3. Wang Y

    . Iron in multiple sclerosis and its noninvasive imaging with quantitative susceptibility mapping. Int J Mol Sci 2016;17:100 doi:10.3390/ijms17010100 pmid:26784172

    CrossRefPubMed
25. 25.↵
    1. Hallgren B,
    2. Sourander P

    . The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41–51 doi:10.1111/j.1471-4159.1958.tb12607.x pmid:13611557

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Haider L,
    2. Simeonidou C,
    3. Steinberger G, et al

    . Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry 2014;85:1386–95 doi:10.1136/jnnp-2014-307712 pmid:24899728

    Abstract/FREE Full Text
27. 27.↵
    1. Hametner S,
    2. Endmayr V,
    3. Deistung A, et al

    . The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation: a biochemical and histological validation study. Neuroimage 2018;179:117–33 doi:10.1016/j.neuroimage.2018.06.007 pmid:29890327

    CrossRefPubMed
28. 28.↵
    1. Benarroch EE

    . Pulvinar: associative role in cortical function and clinical correlations. Neurology 2015;84:738–47 doi:10.1212/WNL.0000000000001276 pmid:25609762

    Abstract/FREE Full Text
29. 29.↵
    1. Poretto V,
    2. Petracca M,
    3. Saiote C, et al

    . A composite measure to explore visual disability in primary progressive multiple sclerosis. Mult Scler J Exp Transl Clin 2017;3:2055217317709620 doi:10.1177/2055217317709620 pmid:28607759

    CrossRefPubMed
30. 30.↵
    1. Cocozza S,
    2. Pontillo G,
    3. Lanzillo R, et al

    . MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in multiple sclerosis. Neuroradiology 2019;61:155–62 doi:10.1007/s00234-018-02150-4 pmid:30617409

    CrossRefPubMed
31. 31.↵
    1. Tedeschi E,
    2. Palma G,
    3. Canna A, et al

    . In vivo dentate nucleus MRI relaxometry correlates with previous administration of gadolinium-based contrast agents. Eur Radiol 2016;26:4577–84 doi:10.1007/s00330-016-4245-2 pmid:26905870

    CrossRefPubMed
32. 32.↵
    1. Harder SL,
    2. Hopp KM,
    3. Ward H, et al

    . Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am J Neuroradiol 2008;29:176–83 doi:10.3174/ajnr.A0770 pmid:17989376

    CrossRefPubMed